Literature DB >> 35403994

Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears?

L Bartalena1, M Marinò2, C Marcocci2, M L Tanda3.   

Abstract

Entities:  

Keywords:  Amyloid encephalopathy; Graves’ orbitopathy; Hearing loss; Inflammatory bowel disease; Teprotumumab; Thyroid-eye disease

Mesh：

Substances：

Year:  2022        PMID： 35403994     DOI： 10.1007/s40618-022-01791-w

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   5.467


× No keyword cloud information.
  18 in total

Review 1.  Clinical practice. Graves' ophthalmopathy.

Authors:  Luigi Bartalena; Maria Laura Tanda
Journal:  N Engl J Med       Date:  2009-03-05       Impact factor: 91.245

2.  New-Onset of Inflammatory Bowel Disease in a Patient Treated With Teprotumumab for Thyroid Associated Ophthalmopathy.

Authors:  Davin C Ashraf; Ivana Jankovic; Najwa El-Nachef; Bryan J Winn; Grace E Kim; Robert C Kersten
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2021-03-08       Impact factor: 1.746

3.  Teprotumumab for Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; George J Kahaly; Daniel G Ezra; James C Fleming; Roger A Dailey; Rosa A Tang; Gerald J Harris; Alessandro Antonelli; Mario Salvi; Robert A Goldberg; James W Gigantelli; Steven M Couch; Erin M Shriver; Brent R Hayek; Eric M Hink; Richard M Woodward; Kathleen Gabriel; Guido Magni; Raymond S Douglas
Journal:  N Engl J Med       Date:  2017-05-04       Impact factor: 91.245

4.  Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.

Authors:  George J Kahaly; Raymond S Douglas; Robert J Holt; Saba Sile; Terry J Smith
Journal:  Lancet Diabetes Endocrinol       Date:  2021-04-15       Impact factor: 32.069

5.  Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.

Authors:  Raymond S Douglas; George J Kahaly; Shoaib Ugradar; Heike Elflein; Katharina A Ponto; Brian T Fowler; Roger Dailey; Gerald J Harris; Jade Schiffman; Rosa Tang; Sara Wester; Amy Patel Jain; Claudio Marcocci; Michele Marinò; Alessandro Antonelli; Anja Eckstein; Dagmar Führer-Sakel; Mario Salvi; Saba Sile; Megan Francis-Sedlak; Robert J Holt; Terry J Smith
Journal:  Ophthalmology       Date:  2021-10-21       Impact factor: 12.079

6.  Teprotumumab for the Treatment of Active Thyroid Eye Disease.

Authors:  Raymond S Douglas; George J Kahaly; Amy Patel; Saba Sile; Elizabeth H Z Thompson; Renee Perdok; James C Fleming; Brian T Fowler; Claudio Marcocci; Michele Marinò; Alessandro Antonelli; Roger Dailey; Gerald J Harris; Anja Eckstein; Jade Schiffman; Rosa Tang; Christine Nelson; Mario Salvi; Sara Wester; Jeffrey W Sherman; Thomas Vescio; Robert J Holt; Terry J Smith
Journal:  N Engl J Med       Date:  2020-01-23       Impact factor: 91.245

7.  A case of ulcerative colitis associated with teprotumumab treatment for thyroid eye disease.

Authors:  Myra B Safo; Rona Z Silkiss
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-10

8.  Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease.

Authors:  Thanh Duc Hoang; Nguyen T Nguyen; Eva Chou; Mohamed Km Shakir
Journal:  BMJ Case Rep       Date:  2021-05-10

9.  The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.

Authors:  L Bartalena; G J Kahaly; L Baldeschi; C M Dayan; A Eckstein; C Marcocci; M Marinò; B Vaidya; W M Wiersinga
Journal:  Eur J Endocrinol       Date:  2021-08-27       Impact factor: 6.664

10.  Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators.

Authors:  Raymond S Douglas; Yao Wang; Roger A Dailey; Gerald J Harris; Sara T Wester; Jade S Schiffman; Rosa A Tang; Brian Fowler; James Fleming; Terry J Smith
Journal:  J Neuroophthalmol       Date:  2021-12-01       Impact factor: 4.415
View more
  1 in total

Review 1.  Recent advances in graves ophthalmopathy medical therapy: a comprehensive literature review.

Authors:  Xueting Li; Senmao Li; Wanlin Fan; Alexander C Rokohl; Sitong Ju; Xiaojun Ju; Yongwei Guo; Ludwig M Heindl
Journal:  Int Ophthalmol       Date:  2022-10-22       Impact factor: 2.029
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.